Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial

Eur Respir J. 2018 May 30;51(5):1800354. doi: 10.1183/13993003.00354-2018. Print 2018 May.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Home Care Services / organization & administration
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Monitoring, Physiologic / methods
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Spain
  • Telemedicine / economics*
  • Telemedicine / methods*

Associated data

  • ClinicalTrials.gov/NCT02499068